Zura Bio (ZURA)

• Market cap: $239M
• 1 day: 5.46%
• 5 days: -5.41%
• 1 month: -8.02%
• 3 months: 147.97%
• 6 months: 198.37%
• Year to date: 56.17%
• 1 year: -17.9%
• 5 years: -62.16%
• 10 years: -62.16%
• Sector: Healthcare
• Industry: Biotechnology

About: Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Employees: 30